Anti-progestin therapy targets hallmarks of breast cancer risk. - Simões BM; Pedley R; McCloskey CW; Roberts M; Reed AD; Twigger AJ; Tharmapalan P; Caruso A; Cabral S; Wilby AJ; Harrison H; Zhou Y; et al. (Nature, 2025)